We are live on ! Find out more
WVP

Worth Venture Partners Portfolio holdings

AUM $31.6M
1-Year Est. Return 28.5%
This Fund
S&P 500
This Quarter Est. Return
+5.78%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$202M
AUM Growth
-$20.4M
Cap. Flow
-$72M
Cap. Flow %
-35.68%
Top 10 Hldgs %
32.61%
Holding
161
New
27
Increased
32
Reduced
22
Closed
30

Top Buys

Rank Stock Value
1
MRAM icon
Everspin Technologies
MRAM
+$3.23M
2
MIRM icon
Mirum Pharmaceuticals
MIRM
+$1.21M
3
LTRX icon
Lantronix
LTRX
+$1.2M
4
SCYX icon
SCYNEXIS
SCYX
+$920K
5
CNTX icon
Context Therapeutics
CNTX
+$872K

Top Sells

Rank Stock Value
1
EMKR
Emcore Corp
EMKR
+$5.2M
2
GRTX
Galera Therapeutics, Inc. Common Stock
GRTX
+$3.83M
3
ADMS
Adamas Pharmaceuticals
ADMS
+$3.1M
4
OIIM
02Micro International
OIIM
+$2.06M
5
AVNW icon
Aviat Networks
AVNW
+$1.5M

Sector Composition

Rank Sector Weight
1 Technology 28.09%
2 Healthcare 11.1%
3 Financials 3.75%
4 Consumer Discretionary 3.07%
5 Real Estate 1.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NMTC icon
76
NeuroOne Medical Technologies
NMTC
$14.7M
$211K 0.1%
+18,161
New +$294K
NLY icon
77
Annaly Capital Management
NLY
$17.1B
$210K 0.1%
6,725
– –
JBGS
78
JBG SMITH
JBGS
$818M
$204K 0.1%
7,100
– –
BILL icon
79
BILL Holdings
BILL
$4.49B
$203K 0.1%
+814
New +$230K
PRBM
80
DELISTED
Parabellum Acquisition Corp.
PRBM
$191K 0.09%
+39,221
New +$384K
CYTHW
81
DELISTED
Cyclo Therapeutics, Inc. Warrant
CYTHW
$149K 0.07%
74,736
-13,954
-16% -$33.6K
CLRB icon
82
Cellectar Biosciences
CLRB
$20.5M
$137K 0.07%
+686
New +$165K
PGRE
83
DELISTED
Paramount Group
PGRE
$117K 0.06%
+14,000
New +$124K
NLSPW
84
DELISTED
NLS Pharmaceutics Warrant
NLSPW
$97K 0.05%
194,560
– –
AMRS
85
PUT
DELISTED
Amyris Inc.
AMRS
$62K 0.03%
+78,100
New +$729K
BYND icon
86
PUT
Beyond Meat
BYND
$292M
$35K 0.02%
+15,500
New +$1.32M
CASA
87
PUT
DELISTED
Casa Systems, Inc. Common Stock
CASA
$31K 0.02%
16,400
– –
PRBM.WS
88
DELISTED
Parabellum Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
PRBM.WS
$31K 0.02%
+139,072
New +$70.4K
VRM icon
89
PUT
Vroom Inc
VRM
$39M
$28K 0.01%
574
+405
+240% +$545K
FSR
90
PUT
DELISTED
Fisker Inc.
FSR
$21K 0.01%
57,900
+31,900
+123% +$552K
DRMAW icon
91
Dermata Therapeutics Warrant
DRMAW
$14.1K
$17K 0.01%
40,075
– –
X
92
PUT
DELISTED
US Steel
X
$17K 0.01%
44,700
+6,800
+18% +$160K
ICPT
93
PUT
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$15K 0.01%
38,300
+2,200
+6% +$37.1K
GES
94
PUT
DELISTED
Guess Inc
GES
$14K 0.01%
37,100
+4,900
+15% +$109K
IMAX icon
95
PUT
IMAX
IMAX
$2.62B
$13K 0.01%
+27,900
New +$535K
PETVW
96
DELISTED
PetVivo Holdings, Inc. Warrant
PETVW
$13K 0.01%
22,900
– –
CCL icon
97
PUT
Carnival Corporation Ltd
CCL
$38.1B
$9K ﹤0.01%
75,000
-1,400
-2% -$29.9K
HOUS
98
PUT
DELISTED
Anywhere Real Estate
HOUS
$9K ﹤0.01%
25,100
+12,900
+106% +$225K
VCRA
99
PUT
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$8K ﹤0.01%
+12,100
New +$680K
AAL icon
100
PUT
American Airlines Group
AAL
$10.1B
$7K ﹤0.01%
30,430
-15,970
-34% -$306K
2 3
4
5 6

Similar funds

VL
Vorpal LLC Nashville, Tennessee $32M AUM 10.89% 1-Year Est. Return
SP
SCF Partners Houston, Texas $32.2M AUM 191.71% 1-Year Est. Return
OGC
One68 Global Capital New York $30.9M AUM
PE
Platinum Equity Beverly Hills, California $32.3M AUM 17.64% 1-Year Est. Return
RL
RPO LLC Stamford, Connecticut $32.3M AUM 14.17% 1-Year Est. Return
AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return
LGM
Lykos Global Management Stamford, Connecticut $30.4M AUM
SCA
SMH Capital Advisors Fort Worth, Texas $32.9M AUM 1.53% 1-Year Est. Return

Worth Venture Partners's Q4 2021 Portfolio in Review

As of Q4 2021, Worth Venture Partners held 161 positions worth $202M, down 9.2% from $222M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Worth Venture Partners withdrew a net $72M in Q4 2021, closing 30 positions and reducing 22 holdings. Its most notable exit was Galera Therapeutics, Inc. Common Stock, an estimated $3.83M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Worth Venture Partners opened a new position in Everspin Technologies worth $4.03M.

  • Worth Venture Partners's largest Q4 2021 buy was Everspin Technologies: 356,722 shares worth $4.03M.
  • Worth Venture Partners added most to SCYNEXIS in Q4 2021, an estimated $920K increase.
  • Worth Venture Partners's biggest Q4 2021 reduction was Emcore Corp, cutting an estimated $5.2M.
  • Worth Venture Partners fully exited Galera Therapeutics, Inc. Common Stock in Q4 2021, selling an estimated $3.83M.
  • Worth Venture Partners's ten largest holdings make up 33% of its $202M portfolio in Q4 2021.
  • Worth Venture Partners opened 27 new positions and closed 30 in Q4 2021.
  • Worth Venture Partners's portfolio value fell 9.2% quarter-over-quarter to $202M.

Based on Worth Venture Partners's 13F filing for Q4 2021, filed 14 Feb 2022.